About Us
The Buchholz Lab
Systems biology and genome engineering are at the forefront of transforming our healthcare system. The Department of Medical Systems Biology at the University Cancer Center of TU Dresden integrates functional genomics, high-throughput biology and genome editing to transform precision medicine. Join us in shaping the future of healthcare science!
Prof. Dr. Frank Buchholz
Frank is passionate about the development and application of functional genomics and genome engineering in biomedical science. He was one of the first scientists to perform genome-scale RNAi screens in human cells, and has pioneered genome surgery as a disruptive new biotechnology. Frank has also been a strong leader in industrial innovation and co-founded several biotechnology companies.
Prof. Dr. Frank Buchholz
Frank is passionate about the development and application of functional genomics and genome engineering in biomedical science. He was one of the first scientists to perform genome-scale RNAi screens in human cells, and has pioneered genome surgery as a disruptive new biotechnology. Frank has also been a strong leader in industrial innovation and co-founded several biotechnology companies.
Research
Find out more about our research
Publications
Follow the work of our researchers
Members
Your contact to our research group members
News
Get to know the news of our research group
News
SaxoCell enters second phase of funding!
30. August 2024
We are excited to share that SaxoCell has been chosen by the Federal Ministry of Education and Research (BMBF) and an independent expert panel to receive funding for a second phase in the…
Lukas Theo Schmitt honoured for his PhD thesis “Prediction of designer-recombinases for DNA editing with generative deep learning”
30. April 2024
On 27 April 2024, the DRESDEN EXCELENCE AWARD was presented to four graduates of Dresden universities by Lord Mayor Dirk Hilbert who honoured their outstanding scientific theses. Among the awardees…
Prof. Dr. Frank Buchholz receives Reinhart Koselleck grant for his project “Research into long-term epigenetic silencing modules to further develop the potential of therapeutic gene editing”
24. April 2024
We are delighted to announce a Reinhart Koselleck project in our research group! As part of its Reinhart Koselleck Programme, the German Research Foundation (DFG) has awarded Prof. Frank Buchholz a…